Li Tu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- Extracellular vesicles in disease 2
- RNA regulation and disease 2
- Co-authors
- Lijun Cai (3 shared papers)Jinyong Tian (2 shared papers)Xiao-Mo Huang (1 shared paper)Guanghong Xie (1 shared paper)Wei Du (1 shared paper)Ran Gu (2 shared papers)Qian Zhang (2 shared papers)Xiang Qu (2 shared papers)
- Journals
- ACS Biomaterials Science & Engineering (2 papers)OncoTargets and Therapy (2 papers)Journal of Colloid and Interface Science (1 paper)Aging (1 paper)Materials Today Chemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Li Tu
13 papers receiving 405 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 178
- Biomaterials 63
- Molecular Biology 255
- Neurology 27
- Biomedical Engineering 93
Countries citing papers authored by Li Tu
This map shows the geographic impact of Li Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Tu more than expected).
Fields of papers citing papers by Li Tu
This network shows the impact of papers produced by Li Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Tu. The network helps show where Li Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 116 | |
| 2 | 2019 | 78 | |
| 3 | 2020 | 47 | |
| 4 | 2020 | 47 | |
| 5 | 2021 | 30 | |
| 6 | 2022 | 24 | |
| 7 | 2019 | 22 | |
| 8 | 2018 | 18 | |
| 9 | 2023 | 12 | |
| 10 | 2022 | 8 | |
| 11 | 2016 | 5 | |
| 12 | 2024 | 3 | |
| 13 | 2025 | 1 | |
| 14 | 2025 | 0 |
About Li Tu
Li Tu is a scholar working on Cancer Research, Molecular Biology, Biomedical Engineering, Materials Chemistry and Biomaterials, having authored 14 papers that have together received 411 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Nanoplatforms for cancer theranostics (4 papers), Advanced Nanomaterials in Catalysis (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer-related molecular mechanisms research (3 papers), Extracellular vesicles in disease (2 papers), RNA regulation and disease (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (178 citations), Biomaterials (63 citations), Molecular Biology (255 citations), Neurology (27 citations) and Biomedical Engineering (93 citations). Li Tu has collaborated with scholars based in China and United States. Frequent co-authors include Lijun Cai, Jinyong Tian, Xiao-Mo Huang, Guanghong Xie, Wei Du, Ran Gu, Qian Zhang, Xiang Qu, Huan Yao and Tian Li. Their work appears in journals such as ACS Biomaterials Science & Engineering, OncoTargets and Therapy, Journal of Colloid and Interface Science, Aging and Materials Today Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.